Avid Bioservices, Inc.
US ˙ NasdaqCM ˙ US05368M1062
TEN SYMBOL NIE JEST JUŻ AKTYWNY

SecurityCDMO / Avid Bioservices, Inc.
InstitutionCommonwealth Equity Services, Inc
Latest Disclosed Ownership57,919 shares
Latest Disclosed Value $ 182,000
Commonwealth Equity Services, Inc reports 86.38% decrease in ownership of CDMO / Avid Bioservices, Inc.

On February 16, 2018 - Commonwealth Equity Services, Inc filed a 13F-HR/A form disclosing ownership of 57,919 shares of Avid Bioservices, Inc. (US:CDMO) valued at $181,866 USD as of September 30, 2017. The entity filed a previous 13F-HR/A on February 16, 2018 disclosing 425,254 shares of Avid Bioservices, Inc.. This represents a change in shares of -86.38% during the quarter. The current value of the position is $723,408 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2018-02-16 2017-09-30 13F/A-1 PEREGRINE PHARMACEUTICALS IN COM PAR 713661502 57,919 -367,335 -86.38 182 -29.73 0.0011
2017-11-07 2017-09-30 13F PEREGRINE PHARMACEUTICALS IN COM PAR 713661502 57,919 -367,335 181
2018-02-16 2017-06-30 13F/A-1 PEREGRINE PHARMACEUTICALS IN COM NEW 713661304 425,254 7,493 1.79 259 -5.13 0.0016
2017-08-11 2017-06-30 13F PEREGRINE PHARMACEUTICALS IN COM NEW 713661304 425,254 7,493 258
2018-02-16 2017-03-31 13F/A-1 PEREGRINE PHARMACEUTICALS IN COM NEW 713661304 417,761 4,500 1.09 273 114.96 0.0018
2017-05-15 2017-03-31 13F PEREGRINE PHARMACEUTICALS IN COM NEW 713661304 417,761 4,500 273
2018-02-16 2016-12-31 13F/A-1 PEREGRINE PHARMACEUTICALS IN COM NEW 713661304 413,261 50 0.01 127 -28.65 0.0009
2017-02-01 2016-12-31 13F PEREGRINE PHARMACEUTICALS IN COM NEW 713661304 413,261 50 127
2016-10-25 2016-09-30 13F PEREGRINE PHARMACEUTICALS IN COM NEW 713661304 413,211 -7,850 -1.86 178 16.34 0.0014
2016-08-04 2016-06-30 13F PEREGRINE PHARMACEUTICALS IN COM NEW 713661304 421,061 -65,900 -13.53 153 -25.37 0.0013
2016-04-27 2016-03-31 13F PEREGRINE PHARMACEUTICALS IN COM NEW 713661304 486,961 27,000 5.87 205 -61.90 0.0018
2016-01-19 2015-12-31 13F PEREGRINE PHARMACEUTICALS IN COM NEW 713661304 459,961 -79,574 -14.75 538 -2.18 0.0051
2015-10-27 2015-09-30 13F PEREGRINE PHARMACEUTICALS IN COM NEW 713661304 539,535 -1,000 -0.19 550 -22.32 0.0058
2015-07-28 2015-06-30 13F PEREGRINE PHARMACEUTICALS IN COM NEW 713661304 540,535 37,240 7.40 708 4.27 0.0070
2015-04-28 2015-03-31 13F PEREGRINE PHARMACEUTICALS IN COM NEW 713661304 503,295 7,304 1.47 679 -1.45 0.0070
2015-01-13 2014-12-31 13F PEREGRINE PHARMACEUTICALS IN COM NEW 713661304 495,991 2,795 0.57 689 2.68 0.0077
2014-10-17 2014-09-30 13F PEREGRINE PHARMACEUTICALS IN COM NEW 713661304 493,196 -190 -0.04 671 -27.69 0.0082
2014-07-23 2014-06-30 13F PEREGRINE PHARMACEUTICALS IN COM NEW 713661304 493,386 -12,000 -2.37 928 -3.33 0.0113
2014-05-07 2014-03-31 13F PEREGRINE PHARMACEUTICALS IN COM NEW 713661304 505,386 24,246 5.04 960 43.50 0.0133
2014-02-11 2013-12-31 13F PEREGRINE PHARMACEUTICALS IN COM NEW 713661304 481,140 4,000 0.84 669 0.15 0.0097
2013-11-04 2013-09-30 13F PEREGRINE PHARMACEUTICALS IN COM NEW 713661304 477,140 -13,288 -2.71 668 5.53 0.0108
2013-07-29 2013-06-30 13F PEREGRINE PHARMACEUTICALS IN COM NEW 713661304 490,428 490,428 633 0.0112
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.